Drawing based on the description in the official product monograph. No photo yet.
“4 mg: white, modified diamond-shaped, scored tablet, engraved 2 "N's" and a vertical scoreline on one side and 4 on the unscored side”
N's pill
Pill with imprint N's is white, diamond and has been identified as Doxazosin Mesylate 4 mg. It is used for high blood pressure and an enlarged prostate (BPH). It is supplied by Teva Canada Limited.
Sold in Canada
Doxazosin Mesylate 4 mg
- Brand
- Teva-Doxazosin
- Imprint
- N's
- Strength
- 4 mg
- Used for
- High blood pressure and an enlarged prostate (BPH)
- Color
- White
- Shape
- Diamond
- Form
- Tablet
- Manufacturer
- Teva Canada Limited
- Drug class
- Alpha blocker (prostate and blood pressure medicine)
- Sold in
- Canada
- DIN
- 02242730
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Doxazosin used for?
Doxazosin is used for high blood pressure and an enlarged prostate (BPH).
- Medicine type
- Alpha blocker (prostate and blood pressure medicine)
Official uses from the US prescribing label
Benign Prostatic Hyperplasia (BPH)
Doxazosin tablet is indicated for the treatment of the signs and symptoms of BPH.
Hypertension
Doxazosin tablet is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Doxazosin tablet may be used alone or in combination with other antihypertensives.
From the FDA-approved label on DailyMed (published Aug 06, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows N's.
- It is white, diamond.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Teva-Doxazosin by Teva Canada Limited.
In Canada: prescription only.
Ingredients
Active: Doxazosin (Doxazosin Mesylate)
Other pills with imprint N's
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
APO LMV 150
Lamivudine 150 mg
White, diamond, 14 mm
Used for HIV
- 10 Amphetamine (Complexed with Sodium Polystyrene Sulfonate), Amphetamine Aspartate, Dextroamphetamine Sulfate 10 mg White, diamond
- APO L60 Lisdexamfetamine Dimesylate 60 mg White, diamond Used for ADHD and binge drinking
- LMV 150 Lamivudine 150 mg White, diamond Used for HIV
- 60 S489 Lisdexamfetamine Dimesylate 60 mg White, diamond Used for ADHD and binge drinking
- A Amlodipine Besylate 2.5 mg White, diamond Used for high blood pressure and heart disease
Other Doxazosin pills
-
APO 093
Doxazosin 1 mg
White, round, 6 mm
Used for high blood pressure and an enlarged prostate (BPH)
-
APO 094
Doxazosin 2 mg
White, capsule, 9 mm
Used for high blood pressure and an enlarged prostate (BPH)
-
D 2
Doxazosin 2 mg
White, capsule, 9 mm
Used for high blood pressure and an enlarged prostate (BPH)
-
APO 095
Doxazosin 4 mg
White, capsule, 11 mm
Used for high blood pressure and an enlarged prostate (BPH)
- ETH266 1 mg Doxazosin Mesylate Gray, oval, 9 mm Used for high blood pressure and an enlarged prostate (BPH)
- ETH267 2 mg Doxazosin Mesylate Yellow, oval, 9 mm Used for high blood pressure and an enlarged prostate (BPH)
- ETH268 4 mg Doxazosin Mesylate Pink, oval, 12 mm Used for high blood pressure and an enlarged prostate (BPH)
- ETH269 8 mg Doxazosin Mesylate Blue, oval, 12 mm Used for high blood pressure and an enlarged prostate (BPH)